期刊文献+

老年人丙戊酸钠脑病10例并文献复习 被引量:8

Clinical characteristics of valproate-induced encephalopathy., analyses of 10 cases
原文传递
导出
摘要 目的分析老年患者丙戊酸钠(VPA)脑病的临床特点,提高对丙戊酸钠脑病的认识。方法回顾性分析我院2003年4月至2011年4月诊治的10例老年VPA脑病患者的临床表现、生化、脑电图(EEG)变化及治疗结果,并结合文献进行总结。结果10例患者中男性8例,女性2例;年龄65~88岁,平均(75.4±10.3)岁;10例中7例单用丙戊酸钠(VPA),另3例合用其他抗癫痫药(AEDs);10例病例的血清VPA水平62.1~122.7mg/L,平均(92.3±30.1)mg/I。;共同临床表现均为意识障碍、认知功能下降;血氨水平56.7~225.1μmol/L,平均(101.4±55.2)μmol/L;肝功能均在正常范围;EEG主要表现为弥漫性的慢波增多,以θ和δ波占优,1例有癫痫样放电增多,1例合并有三相波;所有病例在停用VPA3421d后症状改善。结论VPA脑病在老年患者中并不罕见,突出表现是意识障碍、认知功能下降,多数VPA脑病预后良好,停药后可逐渐恢复正常。 Objective To analysis the clinical features of valproate (VPA)-induced encephalopathy in elderly people in order to improve our cognition toward it. Methods From March 2003 to March 2011, a total of 10 cases with VPA-induced encephalopathy were retrospectively reviewed and summarized. The data collected included clinical manifestations , biochemistry , EEG and therapeutic effects. Results In the 10 cases, 8 were males and 2 females. The age ranged from 65-88 years old (mean age 75.4±10.3 years). 7 subjects were on treatment with VPA alone, and the other 3 in combination with other anti epileptic drugs. The serum VPA level in this study ranged from 62.1-122.7μg/ml with mean of (92.3 ± 30.1) mg/L (normal range 50-100 mg/L). All subjects presented with confusion and cognitive impairment. The serum ammonia level in this study ranged from 56.7-225. 1 μmol/L with mean of (101.4±55.2) μmol/L (normal range 11-32 μmol/L). All cases were with normal liver function. Electroencephalography was characterized by signs of severe encephalopathy with continuous generalized slowing, a predominance of θ and δ activity, occasional bursts of epileptiform discharges and triphasic waves. All cases were improved 3-21 days after VPA withdrawal. Conclusions VPA-induced encephalopathy that manifested in confusion and cognitive impairment is not uncommon in elderly patients and it has a good prognosis and the early withdrawal of VPA leads to improvement in almost all cases.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第1期33-36,共4页 Chinese Journal of Geriatrics
关键词 丙戊酸 脑疾病 Valproic acid Brain diseases
  • 相关文献

参考文献17

  • 1Fassi G, Igoa A, Liste OA. Valproate-induced hyperammonemic encephalopathy: review of cases in the psychiatric setting. Vertex, 2008,19 : 371-377. 被引量:1
  • 2Baganz MD,Dross PE. Valproate acid-induced hyperammonemic MR appearance. Am J Neuroradiol, 1994,15 .. 1779-1781. 被引量:1
  • 3Rath A,Naryanan TJ, Chowdhary GV. Valproate- induced hyperammonemic encephalopathy with normal liver function. Neurol India, 2005, 53:226-228. 被引量:1
  • 4Rehman A,Zafar S. Valproate-induced hyperammonemic encephalopathy. J Coil Physicians Surg Pak,2005,15:571-572. 被引量:1
  • 5张彤,杨学军,董可辉.丙戊酸钠脑病1例报道[J].中国药学杂志,2008,43(9):717-718. 被引量:7
  • 6Tsai MF, Chen CY. Valproate-induced hyperammonemic encephalopathy treated lay hemodialysis. Ren Fail, 2008,30 : 822-824. 被引量:1
  • 7王子高,张建峰,邬军锋,陈英辉,祖衡兵,洪震.丙戊酸钠脑病1例报告[J].临床神经病学杂志,2011,24(6):407-407. 被引量:7
  • 8Mehndiratta MM, Mehndiratta P, Phul P, et al. Valproate-induced hyperammonemic encephalopathy ( VNHE )-a study from tertiary care referral university hospital, north India. J Pak Med Assoc, 2008,58:627-631. 被引量:1
  • 9Murphy JV. Valproate-induced hyperammonemic encephalopathy. Epilepsia, 2002,43 : 1101-1105. 被引量:1
  • 10Chou HF, Yang RC, Chen CY, et al. Valproate- induced hyperammonemic encephalopathy. Pediatr Neonatol, 2008,49 : 201-204. 被引量:1

二级参考文献11

  • 1李国良,肖波.丙戊酸钠脑病[J].国外医学(神经病学.神经外科学分册),2004,31(3):266-269. 被引量:9
  • 2王书举,付朝阳,李德亮,宋雪民,李继华.丙戊酸钠脑病一例报告[J].中国现代神经疾病杂志,2005,5(3):204-205. 被引量:3
  • 3O'NEIL M,DUBREY R W,GROCOTT-MASON R M. Valproate encephalopathy and hyperammonaemia [J]. Postgrad Med J, 2002,78:316-317. 被引量:1
  • 4VOSSLER D G,WILENSKY A J, CAWTHON D F, et al. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy [ J ]. Epilepisia,2002,43 ( 2 ) : 154 -159. 被引量:1
  • 5HAMER H M, KNAKE S, SCHOMBURG U, et al. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate [ J ]. Neurology,2000,54 ( 1 ) :230-232. 被引量:1
  • 6OSUNA M T, BURCET J,RANIO L, et al. Hyperammonemic encephalopathy associated with valproate acid [ J ]. Neurologia, 2003,18 ( 6 ) : 347-350. 被引量:1
  • 7FRASER C M, SILLS G J,FORREST G, et al. Effects of antiepileptic drugs on glutamine synthetase activity in mouse brain [ J ]. Br J Pharmacol, 1999,126 : 1634-1638. 被引量:1
  • 8ALBERTO V, DANIELA T, GUIDO M,et al. Valproate-induced hyperammonemic encephalopathy [ J ] . Metabolic Brain Disease, 2002,17 (4) : 367 -373. 被引量:1
  • 9VERROTTI A, GRECO R, MORGESE G,et al. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs [ J ]. Int J Clin Lab Res, 1999,29:36-40. 被引量:1
  • 10Aubrey L. Severe acute hyperammonemia after brief exposure to valproate [ J ]. Psyehosomatics,2008,49 : 82 - 83. 被引量:1

共引文献10

同被引文献60

  • 1肖志刚,包振明,陈学香.以疼痛为首发癫22例临床误诊分析[J].中国实用神经疾病杂志,2013,16(18):30-31. 被引量:3
  • 2Elms J, Powell KL, van Raay L, et al. Long-term valproate treatment increases brain neuropeptide y expression and decrea- ses seizure expression in a genetic rat model of absence epilepsy [J]. PLoS One,2013,8(9):73 505-73 506. 被引量:1
  • 3Lazzari AA, Dussault PM, Thakore-James M, et al. Preven- tion of bone loss and vertebral fractures in patients with chro-nic epilepsy-Antiepileptic drug and osteoporosis prevention trial[J]. Epilepsia,2013,54(11) :1 997-2 004. 被引量:1
  • 4Minagawa K,Watanabe T,Oyanagi R,et al. Characteristics of women with epilepsy who developed polycystic ovary syn- drome owing to the therapy with valproate sodium[J]. No To Hattatsu, 2013,45 (4): 304-308. 被引量:1
  • 5Phabphal K,Geater A. The association between BsmI poly- morphism and risk factors for atherosclerosis in patients with epilepsy taking valproate[J]. Seizure, 2013, 22 (9) : 692-697. 被引量:1
  • 6MURPHY J V, MARQUARDT K. Asymptomatic hyperammonemia in patients receiving valproic acid ~ J 1. Archives of Nem'ology, 1982, 39(9) : 591-592. 被引量:1
  • 7RATH A, NARYANAN T J, CHOWDHARY G V, et al. Valproate- induced hyperammonemic encephalopathy with normal liver funetiorL[J]. Neurology India, 2005, 53(2) 226-22. 被引量:1
  • 8COULTER D L, ALLEN R J. Secondary hyperammonaemia: a pos- sible mechanism for valproate eneephalopathy[ J]. Laneet, 1980, 1 (8181) : 1310-1311. 被引量:1
  • 9TSAI M F, CHEN C Y. Valproate-induced hyperammonemic enceph- alopathy treated by hemodialyzis[ Jl. Renal Failure, 2008, 30 (8) : 822 -824. 被引量:1
  • 10KUMAR A, SURI A, SHARMA B S. Severe valproate induced hy- perammonemic encephalopathy successfully managed with peritoneal dialysis [ J 1. Indian Journal of Critical Care Medicine, 20 l 4,18 ( 7 ) : 461-463. 被引量:1

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部